DE69020755D1 - Physiologisch aktives Polypeptid und DNA. - Google Patents

Physiologisch aktives Polypeptid und DNA.

Info

Publication number
DE69020755D1
DE69020755D1 DE69020755T DE69020755T DE69020755D1 DE 69020755 D1 DE69020755 D1 DE 69020755D1 DE 69020755 T DE69020755 T DE 69020755T DE 69020755 T DE69020755 T DE 69020755T DE 69020755 D1 DE69020755 D1 DE 69020755D1
Authority
DE
Germany
Prior art keywords
edema
activity
physiologically active
polypeptide
active polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69020755T
Other languages
English (en)
Other versions
DE69020755T3 (de
DE69020755T2 (de
Inventor
Tetsuji Sudoh
Keiji Maekawa
Naoto Minamino
Kenji Kangawa
Hisayuki Matsuo
Atsushi Izumi
Mika Takashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
DAIICHI PURE CHEMICALS Co Ltd TOKIO/TOKYO JP
Daiichi Pure Chemicals Co Ltd
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26390052&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69020755(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from JP04963689A external-priority patent/JP3160276B2/ja
Priority claimed from JP1059183A external-priority patent/JP2883903B2/ja
Application filed by DAIICHI PURE CHEMICALS Co Ltd TOKIO/TOKYO JP, Daiichi Pure Chemicals Co Ltd, Daiichi Pharmaceutical Co Ltd filed Critical DAIICHI PURE CHEMICALS Co Ltd TOKIO/TOKYO JP
Publication of DE69020755D1 publication Critical patent/DE69020755D1/de
Application granted granted Critical
Publication of DE69020755T2 publication Critical patent/DE69020755T2/de
Publication of DE69020755T3 publication Critical patent/DE69020755T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69020755T 1989-03-01 1990-03-01 Physiologisch aktives Polypeptid und DNA. Expired - Lifetime DE69020755T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP04963689A JP3160276B2 (ja) 1989-03-01 1989-03-01 新規ｃＤＮＡフラグメント
JP1059183A JP2883903B2 (ja) 1989-03-10 1989-03-10 新規生理活性ペプチド及びその用途

Publications (3)

Publication Number Publication Date
DE69020755D1 true DE69020755D1 (de) 1995-08-17
DE69020755T2 DE69020755T2 (de) 1996-04-04
DE69020755T3 DE69020755T3 (de) 2000-03-02

Family

ID=26390052

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69020755T Expired - Lifetime DE69020755T3 (de) 1989-03-01 1990-03-01 Physiologisch aktives Polypeptid und DNA.

Country Status (6)

Country Link
EP (1) EP0385476B2 (de)
AT (1) ATE124994T1 (de)
CL (1) CL2004001266A1 (de)
DE (1) DE69020755T3 (de)
DK (1) DK0385476T4 (de)
ES (1) ES2076981T5 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6028055A (en) * 1996-10-22 2000-02-22 Genetech, Inc. Receptor selective BNP
KR100691545B1 (ko) 1998-09-28 2007-03-09 산텐 세이야꾸 가부시키가이샤 나트륨 이뇨 펩티드를 유효 성분으로하는 누액 분비 촉진또는 각결막 장해 치료용 점안제
BR0316560A (pt) 2002-11-26 2005-10-04 Nobex Corp Conjugado de composto natriurético, formulação farmacêutica, método de tratar uma condição, método de preparação do conjugado de composto natriurético, conjugado de peptìdeo pró-polinatriurético modificado, análogo de peptìdeo natriurético, análogo de hbnp, composto, e, método de preparar um composto
EP2004633A4 (de) 2006-03-30 2009-08-26 Palatin Technologies Inc Lineare natriuretische peptidkonstrukte
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
AU2007233116B2 (en) 2006-03-30 2013-05-09 Palatin Technologies, Inc. Cyclic natriuretic peptide constructs
CA2699012A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
PL409596A1 (pl) * 2014-09-25 2016-03-29 Uniwersytet Wrocławski Pochodne pseudofaktyny, sposób otrzymywania pochodnych pseudofaktyny oraz ich zastosowanie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1339210C (en) * 1988-05-31 1997-08-05 John Lewicki Recombinant techniques for production of novel natriuretic and vasodilator peptides

Also Published As

Publication number Publication date
EP0385476A1 (de) 1990-09-05
ATE124994T1 (de) 1995-07-15
DK0385476T4 (da) 1999-12-20
DE69020755T3 (de) 2000-03-02
ES2076981T5 (es) 2000-02-01
DK0385476T3 (da) 1995-10-02
DE69020755T2 (de) 1996-04-04
EP0385476B2 (de) 1999-09-22
ES2076981T3 (es) 1995-11-16
EP0385476B1 (de) 1995-07-12
CL2004001266A1 (es) 2005-02-04

Similar Documents

Publication Publication Date Title
DE69020755T3 (de) Physiologisch aktives Polypeptid und DNA.
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DK163683A (da) Fremstilling af funktionelle humane urokinaseproteiner, dna-sekvens, der koder for et protein omfattende den enzymatiske del af human urokinase, replicerbart udtrykkelsesmedium, der kan udtrykke dna-sekvensen og mikroorganisme eller cellekultur transformeret med mediet
DE3786767T2 (de) Neues Polypeptid.
DE69131514T2 (de) Herstellung von biologisch aktiven rekombinanten Mitgliedern der NGF/BDNF-Familie neurotroper Proteine
FR2613596B1 (fr) Structure de support de pied, a lanieres en echarpe fixees a la semelle externe d'une chaussure
DE68929551D1 (de) Menschliche DNase
DE3582183D1 (de) Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid.
DE3882593D1 (de) Polypeptid und dessen herstellung.
EP0849361A3 (de) Neue Liganden des Neuropeptide Rezeptors HFGAN72
DK215287A (da) Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette
DE3886175T2 (de) Trigramin, ein Polypeptid, das die Aggregation der Blutplättchen hemmt.
IS6072A (is) Æðasamloðunar sameindir og mótun á starfsemi þeirra
DK0512883T3 (da) Fremgangsmåde til fremstilling af et koncentrat af blodkoaguleringsfaktor XI med høj specifik aktivitet, til terapeutisk anvendelse
DE69024693D1 (de) Gene, die ein Protein mit menschlicher MACIF-Aktivität kodieren, Expressionsvektoren mit diesen Genen, Transformantenzellen und Proteine mit menschlicher MACIF-Aktivität
AR243237A1 (es) Un vector de expresion recombinante que contiene una secuencia de adn que codifica el factor neurotrofico ciliar humano,un microorganismo e.coli transformado,y linea celulares transformadas.
DE3886517T2 (de) Menschlicher Prourokinase ähnliches Polypeptid.
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
Burnyasheva et al. On the question of the treatment of urticaria
ATE238780T1 (de) Verwendung von nk1-rezeptor antagonisten zur zubereitung von arzneimitteln mit kardioregulierender wirkung
IT8609416A0 (it) Ventricolo artificiale protesico in sostituzione del ventricolo sinistro, con sistema autoregolante la gittata sistolica
DK164283C (da) Polypeptid med cystatin c aktivitet, dna-sekvens til udtrykkelse af 3-des-oh-cystatin c eller en modifikation deraf, fremgangsmaade til fremstilling af 3-des-hydroxy-cystatin c eller en modifikation deraf, plasmid og mikroorganisme til udoevelse af fremgangsmaaden og anvendelse af 3-des-oh-cystatin c eller en modifikation deraf til fremstilling af et terapeutisk praeparat
ATE61817T1 (de) Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid.
ATE92106T1 (de) Polypeptid und dessen herstellung.
IT8521936V0 (it) Siringa composita del tipo cosiddetto usa e getta, perautoiniezione mediante un predisposto movimento a scatto dell'ago.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: SHIONOGI & CO., LTD., OSAKA, JP MATSUO, HISAYUKI,

8366 Restricted maintained after opposition proceedings